MedPath

RECTAL DICLOFENAC VERSUS INTRAMUSCULAR DICLOFENAC FOR POST OPERATIVE ANALGESIA AFTER MYOMECTOMY: A RANDOMISED STUDY

Not Applicable
Conditions
Post operative pain management following Myomectomy
Registration Number
PACTR202206556144219
Lead Sponsor
Dr Chiadikobi John Irechukwu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Participants willingness to participate in the study

Exclusion Criteria

1. Women that declined consent 2. Women with significant diseases like rectal disorders, peptic ulcer disease, hepatic,hematological and cardiovascular diseases.3. History of chronic pain 4. History of bleeding coagulopathies 5. Use of general anaesthesia 6. Adverse reaction or hypersensitivity to diclofenac or pentazocine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be the pain score assessed using the visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome measures will be patients’ satisfaction which will be assessed after 24 hours of administration of the drugs, the need and frequency of rescue analgesia and maternal side effects
© Copyright 2025. All Rights Reserved by MedPath